ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,714Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 234

$1.02M Total Retail Price of All Prescriptions

Rank: 24 out of 234

438 Patients Receiving at Least One Drug in Part D
15%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 438 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

4% of this provider’s 438 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

6% of this provider’s 748 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$132 was the average price of a prescription from this provider, compared to $151 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
RISPERIDONE 468 32 1 2
FLUOXETINE HCL 371 21 2 10
CYMBALTA 341 24 3 6
QUETIAPINE FUMARATE 306 29 4 8
MIRTAZAPINE 306 56 4 18
TRAZODONE HCL 300 29 6 1
SERTRALINE HCL 293 26 7 3
DIVALPROEX SODIUM ER 272 11 8 12
ABILIFY 267 12 9 4
BUPROPION XL 261 11 10 17
BENZTROPINE MESYLATE 256 27 R 11 5
OLANZAPINE 190 33 12 9
BUSPIRONE HCL 183 56 13 20
ESCITALOPRAM OXALATE 174 0 14 14
DIVALPROEX SODIUM 173 15 15 29
TOPIRAMATE 166 24 16 28
CITALOPRAM HBR 157 36 17 11
HALOPERIDOL 138 0 18 23
VENLAFAXINE HCL ER 135 50 19 16
LAMOTRIGINE 129 0 20 7
AMPHETAMINE SALT COMBO 123 0 S2 21 34
SEROQUEL 122 17 22 31
CLOZAPINE 104 0 23 13
PAROXETINE HCL 104 0 23 24
CLONIDINE HCL 93 13 25 63
BUPROPION HCL SR 86 0 26 25
FLUVOXAMINE MALEATE 86 24 26 48
THIORIDAZINE HCL 84 18 R 28 62
OXCARBAZEPINE 80 0 29 30
ZOLPIDEM TARTRATE 77 0 30 15
ZIPRASIDONE HCL 76 0 31 21
ALPRAZOLAM 73 19 32 56
LITHIUM CARBONATE 73 0 32 19
INVEGA 71 0 34 33
SUBOXONE 69 0 35 50
ZONISAMIDE 68 0 36 91
GUANFACINE HCL 65 0 R 37 87
LATUDA 64 0 38 37
DEXTROAMPHETAMINE-AMPHETAMINE 61 0 S2 39 72
METHYLPHENIDATE HCL 59 13 40 64
SEROQUEL XR 55 0 41 22
GEODON 55 0 41 49
DONEPEZIL HCL 54 36 43 40
LOXAPINE 52 34 44 75
ZYPREXA 50 0 45 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.